AN AUDIT OF INCONTINENCE-ASSOCIATED DERMATITIS PREVALENCE AND SKIN BARRIER PRODUCT USAGE IN NURSING AND RESIDENTIAL HOMES IN A WELSH HEALTH BOARD
Incontinence-Associated Dermatitis (IAD) can occur with exposure of the skin to urine and/or faeces, resulting in skin damage which can range from mild erythema to severe excoriation and skin erosion1,2. IAD prevalence is suggested to be between 5.7% and 27%2, and it is generally acknowledged that IAD is a common problem, particularly in some long-term care settings. IAD can be a painful and debilitating condition.
Management of IAD involves structured regimes including skin-friendly, pH-balanced cleansers and skin barrier protectant products to protect and maintain natural skin barrier function. It is documented, however, that there is often confusion with regards to the difference between pressure and moisture damage1,2, which can lead to inappropriate product use and misconceptions regarding their indication.
Further confusion can also arise due to the multitude of cleansing and barrier products available, leading to inconsistencies with skin care across local areas
An audit was undertaken to gain information on the prevalence of IAD amongst residents of Nursing Homes and larger Residential Homes within a Welsh Health Board, and to determine the main skin barrier products in use in these areas and the perceptions of healthcare professionals in this care environment on the indications for use.